Objective Systemic lupus erythematosus (SLE) is a systemic autoimmune disease with
varied morbidity and mortality. We assessed clinical presentations, autoantibody specificities …

Objective To determine the performance characteristics of enzyme‐based immunoassay
(EIA) kits for the detection of antinuclear and other autoantibodies of defined specificities …

Objective. Analysis of antibodies against dsDNA is an important diagnostic tool for systemic
lupus erythematosus (SLE), and changes in anti-dsDNA antibody levels are also used to …

OBJECTIVE: Description of the various autoantibodies that can be detected in patients with
systemic lupus erythematosus (SLE). METHODS: A literature review, using the terms …

Objective: To better define the serology of a panel of sera from patients with a clinical
diagnosis of systemic lupus erythematosus (SLE) or subacute cutaneous lupus …

Introduction Identification of patients who are in early stages of lupus is currently done
through clinical evaluation and is not greatly facilitated by available diagnostic tests …

Systemic lupus erythematosus (SLE) is a systemic autoimmune inflammatory condition that
may cause inflammation and damage in multiple organ systems and is associated with …

Systemic lupus erythematosus (SLE) is a clinically heterogeneous, humoral autoimmune
disorder. The unifying feature among SLE patients is the production of large quantities of …

INTRODUCTION: Testing for autoantibodies to extractable nuclear antigens (ENA) is
essential in the investigation of connective tissue disease. Counterimmunoelectrophoresis is …

Introduction The finding of antinuclear antibody (ANA) positivity in a healthy individual is
usually of unknown significance and in most cases is benign. However, a subset of such …